• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    20 Years: A Discussion on the Past & Future of Medical Product Outsourcing

    A Combined Effort for Drug Delivery & Combo Product Technology

    Examining Medical Packaging & Sterilization on Multiple Fronts

    Medical Molding Modernized

    Computer Concepts for Medical Device Design
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Olympus Releases Next-Gen ESG-410 Electrosurgical Generator

    NICO Corporation Touts Positive ENRICH Trial Results

    Study Reveals Graphene-Based Biosensors' Potential in Detecting Critical Biomarker

    Obvius Robotics Completes First-in-Human Cases

    Gore Begins Enrollment for VIAFORT Vascular Stent Iliofemoral Study
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    20 Years: A Discussion on the Past & Future of Medical Product Outsourcing

    A Combined Effort for Drug Delivery & Combo Product Technology

    Examining Medical Packaging & Sterilization on Multiple Fronts

    Medical Molding Modernized

    Computer Concepts for Medical Device Design
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Elizabeth Holmes’ Pre-Prison Public Persona

    Trending in Healthcare Dealmaking: Creativity, Diversification, and Distress

    How Human Factors Engineering Can Contribute to Medical Device Packaging

    How Companies Can Create a Unique Selling Proposition

    Updating Medical Device Software in the Field
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    Fusion Biotec Inc.

    JBC Technologies

    Providence Enterprise USA Inc.

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How the CHIPS Act and R&D Tax Credits Will Shape the Medtech Manufacturing Landscape

    Solving the Skills Gap Stalling the March of UK Life Sciences

    5 Ways to Reduce Nearshoring & Reshoring Costs Using Automation

    The Future of Hearing Aids: xMEMS Develops All-Silicon, Solid-State Micro Speaker

    Navigating Chinese Regulatory Requirements for Medical Device Localization
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    Fusion Biotec Inc.

    JBC Technologies

    Providence Enterprise USA Inc.

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA’s Efforts to Strengthen the Medical Device Cybersecurity Program

    A cybersecurity “playbook” for healthcare delivery organizations focused on promoting cybersecurity readiness was launched.

    FDA’s Efforts to Strengthen the Medical Device Cybersecurity Program
    Scott Gottlieb, M.D., Commissioner, U.S. Food and Drug Administration10.02.18
    The threat of cyberattacks is no longer theoretical. Cybercriminals and adversaries can inflict significant harm on networks through relatively simple methods, like emails or bugs known as malware.
     
    In recent years, we’ve witnessed the far-reaching and negative consequences of successful cyber campaigns on organizations. Victims include financial institutions, government agencies, and now healthcare systems. Even when medical devices are not being deliberately targeted, if these products are connected to a hospital network, such as radiologic imaging equipment, they may be impacted.
     
    As the number of cyberattacks has increased, we’ve heard concerns about the potential for cybercriminals to attack patient medical devices. Cybersecurity researchers, often referred to as “white hat hackers” have identified device vulnerabilities in non-clinical, research-based settings. They’ve shown how bad actors could gain the capability to exploit these same weaknesses, thereby acquiring access and control of medical devices. The FDA isn’t aware of any reports of an unauthorized user exploiting a cybersecurity vulnerability in a medical device that is in use by a patient. But the risk of such an attack persists. And we understand that the threat of such an attack can cause alarm to patients who may have devices that are connected to a network. We want to assure patients and providers that the FDA is working hard to be prepared and responsive when medical device cyber vulnerabilities are identified.
     
    At the FDA, we‘ll continue to put protecting patients at the forefront of what we do. We are building on a foundation of shared responsibility with our stakeholders. In coordination with the MITRE Corporation, we’re announcing the launch of a cybersecurity “playbook” for healthcare delivery organizations that’s focused on promoting cybersecurity readiness. We’re also announcing the signing of two significant memoranda of understanding. These agreements bring together multiple stakeholders to allow for increased information sharing and transparency around cybersecurity risks.
     
    Securing medical devices from cybersecurity threats cannot be achieved by one government agency alone. Every stakeholder—manufacturers, hospitals, health care providers, cybersecurity researchers, and government entities—all have a unique role to play in addressing these modern challenges. That’s why the FDA has long been committed to working hard with various stakeholders to stay a step ahead of constantly evolving cybersecurity vulnerabilities. In this way, we can ensure the healthcare sector is well positioned to proactively respond when cyber vulnerabilities are identified in products that we regulate.
     
    Our Center for Devices and Radiological Health (CDRH) has taken a holistic, systematic approach to building our medical device cybersecurity program, as well as creating an environment where industry and other stakeholders understand the importance of this shared responsibility.
     
    The FDA’s work in this area dates back to 2013, when we established the foundations of our medical device cybersecurity program. We created a Cybersecurity Working Group within CDRH that’s well-poised to respond to concerns and actively addresses the need for new approaches and new policies. We also established a framework to address cybersecurity regulatory considerations which, taken together, represent our recommendations for product developers at each stage of a product’s lifecycle.
     
    Our premarket guidance identifies issues manufacturers should consider in the design and development of their medical device to ensure their product adequately addresses cybersecurity vulnerabilities. Our postmarket guidance outlines a risk-based framework manufacturers should use to ensure they can quickly and adequately respond to new cybersecurity threats once a device is in use. The FDA’s policy leverages the National Institute for Standards and Technology’s Framework for Improving Cybersecurity of Critical Infrastructure. This underscores the importance of adoption by medical device manufacturers of the Framework’s five core functions—identify, protect, detect, respond and recover. The FDA does not compartmentalize its premarket and postmarket activities, nor assess them in isolation.
     
    The premarket guidance was finalized in 2014. In the coming weeks, we plan to publish a significant update to that guidance to reflect the FDA’s most current understandings of, and recommendations regarding, this evolving space. For instance, the new draft guidance will highlight the utility of providing customers and users with a “cybersecurity bill of materials”—a list of commercial and/or off-the-shelf software and hardware components of a device that could be susceptible to vulnerabilities. Depending on the level of cybersecurity risk associated with a device, this list can be an important resource to help ensure that device customers and users are able to respond quickly to potential threats. We look forward to comments from stakeholders on the updated recommendations and how the FDA can continue to advance our regulatory approach to keep pace with changing cybersecurity risks.
     
    Beyond our own policies, the FDA works proactively to create an environment of shared responsibility with diverse stakeholders, including other government agencies, industry, health care delivery organizations, cybersecurity researchers and others. These collaborations include actions through public-private coordinating councils and engagement directly with industry and patients alike.
     
    Our efforts have yielded tools to advance cybersecurity awareness and readiness. For example, we’ve supported the development of a tool to help healthcare delivery organizations (HDOs), such as hospitals, better respond to medical device cybersecurity incidents. Following recent cybersecurity attacks, the FDA recognized a need to close a gap in HDO readiness and response tactics to incidents or exploits affecting medical devices. I’m pleased to announce that the MITRE Corporation, with support from the FDA, released a Medical Device Cybersecurity Regional Incident Preparedness and Response Playbook.  The playbook describes the types of readiness activities that’ll enable HDOs to be better prepared for a cybersecurity incident involving their medical devices. These include steps such as developing a medical device inventory and conducting training exercises. The goal is to give product developers more opportunity to address the potential for large-scale, multi-patient impact that may raise patient safety concerns. The FDA also developed our own internal playbook to help our staff address cybersecurity threats, vulnerabilities, and incidents. Our internal playbook establishes an effective and appropriate incident plan that’s flexible and clear. It aims to help the agency respond in a timely manner to medical device cybersecurity attacks—mitigating impacts to devices, health care systems and ultimately, patients.
     
    Another example of our commitment to shared responsibility is our announcement of two memoranda of understanding with multiple stakeholder groups to create information sharing analysis organizations (ISAOs)—groups of experts that gather, analyze and disseminate important information about cyber threats. As we noted in our post-market cybersecurity guidance, the FDA believes that manufacturers that participate in ISAOs signal they’re being proactive in addressing cybersecurity.
     
    In these ISAO forums, manufacturers have the opportunity to share information about potential vulnerabilities and emerging threats. We believe this transparent sharing of information will help manufacturers address issues earlier and result in more protection for patients.
     
    We also recognize that our part in shared responsibility is partnering with other government agencies to strengthen our preparation for and response to cybersecurity threats. This includes discussions with the U.S. Department of Homeland Security (DHS) about executing a memorandum of agreement (MOA) related to our inter-agency work on medical device cybersecurity. We’ll share additional details about this MOA in the future, but our goal is to provide a durable framework for coordination and information sharing between the two agencies about medical device cybersecurity vulnerabilities and threats. We believe this type of coordination will lead to more timely and better responses to potential threats to patient safety.
     
    Our partnering also extends to joint cybersecurity exercises that simulate scenarios involving medical device cybersecurity threats. The FDA has been exploring steps to continue building on the work that our stakeholders and the agency have already achieved toward these ends. We based these activities on our evolving experience from engagement with stakeholders, our review of premarket submissions, investigations of device-specific vulnerabilities, and participation in functional and tabletop exercises simulating medical device cybersecurity threats. These exercises include the DHS-led ‘Cracked Domain’ functional exercise in 2013, the DHS-Led Capstone National Level Exercise in 2016, AdvaMed’s Cybersecurity Summit in 2016, and a MITRE-convened table top on behalf of the FDA in 2017. Most recently, we’ve also had the opportunity to gain further insight into the discovery of device vulnerabilities and to continue cultivating our working relationship with the security researcher community by being present and participating with manufacturers in the DefCon Biohacking Village—Medical Device Hacking Lab in 2018.
     
    Finally, we’re taking steps to bring additional resources to the FDA to continue building our medical device cybersecurity program. In the FDA’s Fiscal Year 2019 Budget, we proposed to create a Center of Excellence for Digital Health. This Center of Excellence would help establish more efficient regulatory paradigms, consider the building of new capacity to evaluate and recognize third-party certifiers, and support a cybersecurity unit to complement the advances in software-based devices. 
     
    When we issued our Medical Device Safety Action Plan in April, we outlined our vision for how the FDA will continue to enhance our programs and processes to assure the safety of medical devices including advancing medical device cybersecurity. Our actions, and those we’ll take in the coming weeks, build on that effort. We’re committed to staying ahead of these risks and unscrupulous cybercriminals who may seek to use cybersecurity vulnerabilities in a way that puts patient lives in danger. In order to protect against these threats and mitigate them when they do emerge, we must be forward leading and nimble. Continuing to proactively address medical device cybersecurity is a key priority for the FDA. We remain fully committed to protecting American patients by fully addressing these emerging threats.
    Related Searches
    • medical device manufacturers
    • cybersecurity
    • medical
    • flexible
    Related Knowledge Center
    • Software & IT
      Loading, Please Wait..

      Trending
      • Olympus To Establish Digital Excellence Centers
      • A New Approach To Post-Market Surveillance
      • Philips Names New Supervisory Board Chairman
      • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
      • Labcorp's Clinical Development Spinoff To Be Called Fortrea
      Breaking News
      • PDC Partners with David Schnur Associates to Provide Manufacturing Solutions
      • Olympus Releases Next-Gen ESG-410 Electrosurgical Generator
      • NICO Corporation Touts Positive ENRICH Trial Results
      • Study Reveals Graphene-Based Biosensors' Potential in Detecting Critical Biomarker
      • Obvius Robotics Completes First-in-Human Cases
      View Breaking News >
      CURRENT ISSUE

      June 2023

      • 20 Years: A Discussion on the Past & Future of Medical Product Outsourcing
      • A Combined Effort for Drug Delivery & Combo Product Technology
      • Examining Medical Packaging & Sterilization on Multiple Fronts
      • Medical Molding Modernized
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Publishes Report on EPA and DHA’s Impact on Brain Health
      Alkemist Labs Creates Validated Method for Plant and Fungi-Based Psychedelics
      Reproductive Factors, Menopause Play Understated Role in Heart Health Risk
      Coatings World

      Latest Breaking News From Coatings World

      Sandrine Garnier Joins ChemQuest as a Director
      Greenbuild Announces 2023 Keynote Speaker
      PPG’s New Paint for a New Start Initiative to Beautify Schools Worldwide with Colorful Makeovers
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Olympus Releases Next-Gen ESG-410 Electrosurgical Generator
      NICO Corporation Touts Positive ENRICH Trial Results
      Study Reveals Graphene-Based Biosensors' Potential in Detecting Critical Biomarker
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Qosina, Carolina Components Partner to Market Bioprocess Components
      Astellas, KateTx Enter Exclusive License Agreement to Develop KT430
      Telix Opens $21.2M European Radiopharmaceutical Production Facility
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Boots CFO Michael Snape Resigns
      Beiersdorf Shares Progress of Its Sustainability Agenda
      Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
      Happi

      Latest Breaking News From Happi

      FDA Sends Warning Letter To Maker of Mr. Lulu Sunscreen Drops
      Enhanced Sustainable Nivea Sun and Lip Care Products
      Lysol’s New Mobile Science Center Will Visit Youth Sporting Events to Educate Families on Good Laundry Habits
      Ink World

      Latest Breaking News From Ink World

      SICPA Inaugurates Its unlimitrust Campus
      Siegwerk’s Center of Excellence in France Receives Facelift
      Epson announces MakeTheSwitch Campaign
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Gallus to celebrate 100 years, opening new Gallus Experience Center
      Mark Andy holds successful Low Migration Workshop
      Ryback & Ryback Consulting launches Machinery division
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Terra Baby Diapers, Wipes Launch in U.S. and Canada
      The Honest Company to Exit Europe, Asia
      TechnoPlants to Exhibit at ITMA
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Osso VR Launches Virtual Reality Training Program
      Catalyst OrthoScience Names Mark Quick as CFO
      European Regulators Approve Amber Implants' VCFix Spinal System Study
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Sensormatic Unveils Sensormatic Synergy Media Display
      ams OSRAM Receives the German Innovation Award
      ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login